Vascular Clinical Trials
CLI & AMI

Blood and Bone Marrow
Bioprocessing

Bone Marrow Transplant
Innovation

News Updates

CESCA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL FISCAL 2014 RESULTS

September 29, 2014

Company Completes Year of Transformation, Makes Regulatory Advances in Clinical Progra...

Read More >>

Cesca Therapeutics Reschedules Fourth Quarter and Full Year Earnings R...

September 25, 2014

RANCHO CORDOVA, Calif., September 25, 2014 -- Cesca Therapeutics Inc. (NASDAQ: KOOL), an autologous ...

Read More >>

Video Library